Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease

scientific article published on 26 April 2018

Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CGH.2018.04.043
P932PMC publication ID6203668
P698PubMed publication ID29705261

P50authorDavid E. KleinerQ41449492
Raj VuppalanchiQ56427124
Srinivasan DasarathyQ59167255
Manal F AbdelmalekQ59194524
Nonalcoholic Steatohepatitis Clinical Research NetworkQ110296507
Kris V. KowdleyQ110296712
P2093author name stringNaga Chalasani
Arun J Sanyal
Rohit Loomba
Mohammad S Siddiqui
Mark L Van Natta
Brent A Neuschwander-Tetri
Edward Doo
Danielle Brandman
Erin Hallinan
James A Tonascia
P2860cites workDesign and validation of a histological scoring system for nonalcoholic fatty liver diseaseQ29614930
Long-term follow-up of patients with NAFLD and elevated liver enzymesQ29620024
Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.Q30382172
NASH and cryptogenic cirrhosis: a histological analysis.Q30449747
Discordance between liver biopsy and Fibroscan® in assessing liver fibrosis in chronic hepatitis b: risk factors and influence of necroinflammationQ34182393
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver DiseaseQ35893923
The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver DiseaseQ36880302
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver DiseaseQ40444861
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.Q44964478
Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver diseaseQ45024243
Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinationsQ46078112
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.Q53162511
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosisQ57782665
Expanding consensus in portal hypertensionQ58034372
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver DiseaseQ58622754
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver diseaseQ58803093
Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver diseaseQ59352709
Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver diseaseQ82648058
Liver biopsyQ83395480
Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis BQ84328358
Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver diseaseQ86582636
Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver diseaseQ87406034
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectsteatosisQ1365091
metabolic dysfunction–associated steatotic liver diseaseQ1546498
fatty liver diseaseQ6058862
P304page(s)156-163.e2
P577publication date2018-04-26
P1433published inClinical Gastroenterology and HepatologyQ5133759
P1476titleVibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
P478volume17

Reverse relations

cites work (P2860)
Q104568218Accuracy of Controlled Attenuation Parameter and Liver Stiffness Measurement in Patients with Non-alcoholic Fatty Liver Disease
Q58601451Comparison of FIB-4 and transient elastography in evaluating liver fibrosis of chronic hepatitis C subjects in community
Q90583920Cost Saving or Cost Effective? Unanswered Questions in the Screening of Patients With Nonalcoholic Fatty Liver Disease
Q91600205Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum
Q104283794Elevated Glycated Hemoglobin Is Associated With Liver Fibrosis, as Assessed by Elastography, in a Population-Based Study of Mexican Americans
Q92894259Free fatty acid-based low-impedance liver image: a characteristic appearance in nonalcoholic steatohepatitis (NASH)
Q90091780Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels
Q90580674Impact of Implementing a "FIB-4 First" Strategy on a Pathway for Patients With NAFLD Referred From Primary Care
Q89600297Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant
Q91695771Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study
Q92521100Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness
Q64987408Past, present and future perspectives in nonalcoholic fatty liver disease.
Q91552287Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance
Q90746484Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease
Q91844754Screening for non-alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter-transient elastography
Q100994720The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease
Q90737883Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference

Search more.